Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

73.74%

Threshold

Crossed downwards

Timeline

Published

05.07.2023

Transaction

28.06.2023

Voting rights breakdown

Voting rights acquired15.23%
Voting rights sold73.74%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAN7400088

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Reverse share split in the ratio of 10:1 Regarding certain sale positions

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open